Do Deauville Scores Improve the Clinical Utility of End-of-Therapy FDG PET Scans for Pediatric Hodgkin Lymphoma?
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 30476458.
- Also identified by DOI 10.2214/AJR.18.19755.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study was to evaluate the clinical utility of Deauville scores in interpretation of end-of-chemotherapy FDG PET scans. Deauville scores improve the clinical utility of end-of-chemotherapy PET, as evidenced by an increase in positive predictive value to 72.7% from 44.4% on the basis of report alone. The negative predictive value remains greater than 95%.
Medical subject headings
- Fluorodeoxyglucose F18
- Hodgkin Disease
- Positron-Emission Tomography
- Radiopharmaceuticals